ArticleCell reports. Medicine2024

A PD-1-targeted, receptor-masked IL-2 immunocytokine that engages IL-2Rα strengthens T cell-mediated anti-tumor therapies.

Jiaxi Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.